Hereditary Angioedema - 34 Studies Found
Completed |
: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects : Hereditary Angioedema : 2007-02-07 : Drug: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-02-21 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks : Hereditary Angioedema : 2007-04-17 : Biological: C1 esterase inhibitor [human] (C1INH-nf) |
Completed |
: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-07-29 :
|
Recruiting |
: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients : Hereditary Angioedema : 2011-05-19 : Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The |
Completed |
: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 : Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack |
Completed |
: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3) : Hereditary Angioedema : 2009-06-02 :
|
Completed |
: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-07-12 :
|
Withdrawn |
: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema : Hereditary Angioedema : 2010-12-02 : Biological: ecallantide 10 - 30mg subcutaneous injection. |
Completed |
: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 : Hereditary Angioedema : 2010-03-24 : Biological: CINRYZE Other Name: C1 inhibitor [human] |